Frank L. Hurley, Ph.D. - Managing Director and Chief Scientific Officer

Dr. Hurley has more than 30 years of experience in assisting companies with their regulatory, research, and product development strategies; including clinical trial design and analysis, review of preclinical and clinical information, preparation of regulatory documents, and presentations to government regulatory agencies. Dr. Hurley is a recognized, published educator and authority on research strategy and study design for pharmaceuticals, biologics, and medical devices. Dr. Hurley co-founded BRI International, Inc. in 1971 and guided its growth as both Chairman and Chief Scientific Officer until he merged BRI with Quintiles Transnational, Inc. in 1996. Dr. Hurley served as Chief Scientific Officer of Quintiles until 2001.